The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
X-linked adrenoleukodystrophy in women: a cross-sectional cohort study
Abstract
X-linked adrenoleukodystrophy is the most common peroxisomal disorder. The disease is caused by mutations in the ABCD1 gene that encodes the peroxisomal transporter of very long-chain fatty acids. A defect in the ABCD1 protein results in elevated levels of very long-chain fatty acids in plasma and tissues. The clinical spectrum in males with X-linked adrenoleukodystrophy has been well described and ranges from isolated adrenocortical insufficiency and slowly progressive myelopathy to devastating cerebral demyelination. As in many X-linked diseases, it was assumed that female carriers remain asymptomatic and only a few studies addressed the phenotype of X-linked adrenoleukodystrophy carriers. These studies, however, provided no information on the prevalence of neurological symptoms in the entire population of X-linked adrenoleukodystrophy carriers, since data were acquired in small groups and may be biased towards women with symptoms. Our primary goal was to investigate the symptoms and their frequency in X-linked adrenoleukodystrophy carriers. The secondary goal was to determine if the X-inactivation pattern of the ABCD1 gene was associated with symptomatic status. We included 46 X-linked adrenoleukodystrophy carriers in a prospective cross-sectional cohort study. Our data show that X-linked adrenoleukodystrophy carriers develop signs and symptoms of myelopathy (29/46, 63%) and/or peripheral neuropathy (26/46, 57%). Especially striking was the occurrence of faecal incontinence (13/46, 28%). The frequency of symptomatic women increased sharply with age (from 18% in women <40 years to 88% in women >60 years of age). Virtually all (44/45, 98%) X-linked adrenoleukodystrophy carriers had increased very long-chain fatty acids in plasma and/or fibroblasts, and/or decreased very long-chain fatty acids beta-oxidation in fibroblasts. We did not find an association between the X-inactivation pattern and symptomatic status. We conclude that X-linked adrenoleukodystrophy carriers develop an adrenomyeloneuropathy-like phenotype and there is a strong association between symptomatic status and age. X-linked adrenoleukodystrophy should be considered in the differential diagnosis in women with chronic myelopathy and/or peripheral neuropathy (especially with early faecal incontinence). ABCD1 mutation analysis deserves a place in diagnostic protocols for chronic non-compressive myelopathy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is becoming increasingly recognized that the majority of women are not merely carriers, but may develop some degree of myeloneuropathy leading to gait, bowel, and bladder dysfunction [14,15,63].”
From Structure and Function of the ABCD1 Variant Database: 20 Years, 940 Pathogenic Variants, and 3400 Cases of Adrenoleukodystrophy (2022) · cites this paper as [14]
In the citing paper
“Peripheral neuropathy is a common feature of ALD but is rarely the presenting symptom.7,14-16”
From International Recommendations for the Diagnosis and Management of Patients With Adrenoleukodystrophy (2022) · cites this paper as [7]
In the citing paper
“Female patients with ALD remain asymptomatic in childhood and adolescence, while in adulthood, myeloneuropathy symptoms can arise.7,14”
From International Recommendations for the Diagnosis and Management of Patients With Adrenoleukodystrophy (2022) · cites this paper as [7]
In the citing paper
“Women develop myeloneuropathy; men can develop all 3 syndromes.7-9”
From International Recommendations for the Diagnosis and Management of Patients With Adrenoleukodystrophy (2022) · cites this paper as [7]
In the citing paper
“It was recently reported that all male and possibly even most female patients will develop at least some symptoms of AMN late in life and thus AMN has a near 100% lifetime penetrance.12,14,23”
From The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis (2015) · cites this paper as [12]
In the citing paper
“A recent prospective cross-sectional cohort study including 46 heterozygous X-ALD females reported that 18% of women under the age of 40 years had symptoms but in the age group 60 years or older, 88% were symptomatic.12”
From The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis (2015) · cites this paper as [12]
In the citing paper
“However, the majority of female carriers have elevated plasma VLCFA levels, although to a lesser extent than male patients, and the rate of beta-oxidation of VLCFAs was found to be decreased in fibroblasts.12”
From The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis (2015) · cites this paper as [12]
In the citing paper
“During recent more detailed studies, it became apparent that a high number, if not all, of the heterozygous females develop at least some symptoms of AMN and that the severity of symptoms increases with age.12,24,89”
From The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis (2015) · cites this paper as [12]
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
Aaronson, N. K., Muller, M., Cohen, P. D. A., Essink-Bot, M.-L., Fekkes, M., Sanderman, R., Sprangers, M. A. G., te Velde, A., & Verrips, E. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00097-3 · Cited by 2,276
X-inactivation profile reveals extensive variability in X-linked gene expression in females
Carrel, L., & Willard, H. F. (2005) · Nature · doi:10.1038/nature03479 · Cited by 2,097
PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS.
Ashworth, B. (1964) · PubMed · Cited by 1,475
Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., Moser, H., Poustka, A.-M., Mandel, J.-L., & Aubourg, P. (1993) · Nature · doi:10.1038/361726a0 · Cited by 1,202
Self-citationEngelen, M., Kemp, S., de Visser, M., van Geel, B. M., Wanders, R. J., Aubourg, P., & Poll-The, B. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-51 · Cited by 562
Self-citationHereditary spastic paraplegia: clinical features and pathogenetic mechanisms
Salinas, S., Proukakis, C., Crosby, A., & Warner, T. T. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70258-8 · Cited by 474
Moser, H. (1981) · doi:10.1212/wnl.31.10.1241 · Cited by 396
Migeon, B. R., Moser, H. W., Moser, A. B., Axelman, J., Sillence, D., & Norum, R. A. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.8.5066 · Cited by 283
The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl–CoA esters
van Roermund, C. W. T., Visser, W. F., IJlst, L., van Cruchten, A., Boek, M., Kulik, W., Waterham, H. R., & Wanders, R. J. A. (2008) · The FASEB Journal · doi:10.1096/fj.08-110866 · Cited by 233
Self-citationThe role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy
Ofman, R., Dijkstra, I. M. E., van Roermund, C. W. T., Burger, N., Turkenburg, M., van Cruchten, A., van Engen, C. E., Wanders, R. J. A., & Kemp, S. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000061 · Cited by 170
Self-citationX linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy
van Geel, B. M., Assies, J., Wanders, R. J. A., & Barth, P. G. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.1.4 · Cited by 162
Self-citationAnalysis of very long-chain fatty acids using electrospray ionization mass spectrometry
Valianpour, F., Selhorst, J. J. M., van Lint, L. E. M., van Gennip, A. H., Wanders, R. J. A., & Kemp, S. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00098-2 · Cited by 150
Self-citationClinical aspects of adrenoleukodystrophy and adrenomyeloneuropathy
Moser, H. W., Moser, A. B., Naidu, S., & Bergin, A. (1991) · Developmental Neuroscience · doi:10.1159/000112170 · Cited by 139
Preferential X chromosome loss but random inactivation characterize primary biliary cirrhosis†
Miozzo, M. R., Selmi, C. F., Gentilin, B., Grati, F. R., Sirchia, S. M., Oertelt‐Prigione, S., Zuin, M. G., Gershwin, M. E., Podda, M., & Invernizzi, P. (2007) · Hepatology · doi:10.1002/hep.21696 · Cited by 136
Biochemical aspects of X-linked adrenoleukodystrophy
Kemp, S., & Wanders, R. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00391.x · Cited by 116
Self-citationKemp, S., Theodoulou, F. L., & Wanders, R. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01435.x · Cited by 115
Self-citationAccurate DNA-Based Diagnostic and Carrier Testing for X-Linked Adrenoleukodystrophy
Boehm, C. D., Cutting, G. R., Lachtermacher, M. B., Moser, H. W., & Chong, S. S. (1999) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1998.2779 · Cited by 112
Identification of female carriers of adrenoleukodystrophy
Moser, H. W., Moser, A. E., Trojak, J. E., & Supplee, S. W. (1983) · The Journal of Pediatrics · doi:10.1016/s0022-3476(83)80775-6 · Cited by 99
Post, B., Muslimović, D., van Geloven, N., Speelman, J. D., Schmand, B. A., de Haan, R. J., & on behalf of the CARPA‐study group (2011) · Movement Disorders · doi:10.1002/mds.23467 · Cited by 96
The natural history of Charcot-Marie-Tooth type 1A in adults: a 5-year follow-up study
Verhamme, C., van Schaik, I. N., Koelman, J. H. T. M., de Haan, R. J., & de Visser, M. (2009) · Brain · doi:10.1093/brain/awp251 · Cited by 90
Self-citationvan Geel, B. M., Assies, J., Weverling, G. J., & Barth, P. G. (1994) · Neurology · doi:10.1212/wnl.44.12.2343 · Cited by 90
Bièche, I. (2001) · Carcinogenesis · doi:10.1093/carcin/22.9.1521 · Cited by 87
Koelman (1996) · doi:10.1212/wnl.46.1.112 · Cited by 78
Symptoms in carriers of adrenoleukodystrophy relate to skewed X inactivation
Maier, E. M., Kammerer, S., Muntau, A. C., Wichers, M., Braun, A., & Roscher, A. A. (2002) · Annals of Neurology · doi:10.1002/ana.10376 · Cited by 72
MRI and proton MRSI in women heterozygous for X-linked adrenoleukodystrophy
Fatemi, A. S., Barker, P. B., Uluğ, A. M., Nagae‐Poetscher, L. M., Beauchamp, N. J., Moser, A. B., Raymond, G. V., Moser, H. W., & Naidu, S. (2003) · Neurology · doi:10.1212/01.wnl.0000059546.15529.cb · Cited by 71
Lovastatin in X-Linked Adrenoleukodystrophy
Engelen, M., Ofman, R., Dijkgraaf, M. G. W., Hijzen, M., van der Wardt, L. A., van Geel, B. M., de Visser, M., Wanders, R. J. A., Poll‐The, B. T., & Kemp, S. (2010) · New England Journal of Medicine · doi:10.1056/nejmc0907735 · Cited by 66
Self-citationAdrenoleukodystrophy in female heterozygotes: underrecognized and undertreated
Jangouk, P., Zackowski, K. M., Naidu, S., & Raymond, G. V. (2012) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.11.001 · Cited by 63
Adrenoleukodystrophy: Clinical and biochemical manifestations in carriers
O'Neill, B. P., Moser, H. W., Saxena, K. M., & Marmion, L. C. (1984) · Neurology · doi:10.1212/wnl.34.6.798 · Cited by 56
Restuccia, D. (1997) · Brain · doi:10.1093/brain/120.7.1139 · Cited by 53
Assessment of Adrenal Function in Women Heterozygous for Adrenoleukodystrophy1
El-Deiry, S. S., Naidu, S., Blevins, L. S., & Ladenson, P. W. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.3.3802 · Cited by 53
Zhang, X., De Marcos Lousa, C., Schutte-Lensink, N., Ofman, R., Wanders, R. J., Baldwin, S. A., Baker, A., Kemp, S., & Theodoulou, F. L. (2011) · Biochemical Journal · doi:10.1042/bj20110249 · Cited by 43
Self-citationKemp, S., Valianpour, F., Mooyer, P. A. W., Kulik, W., & Wanders, R. J. A. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2004.038539 · Cited by 40
Self-citationDiffusion tensor–based imaging reveals occult abnormalities in adrenomyeloneuropathy
Dubey, P., Fatemi, A., Huang, H., Nagae‐Poetscher, L., Wakana, S., Barker, P. B., van Zijl, P., Moser, H. W., Mori, S., & Raymond, G. V. (2005) · Annals of Neurology · doi:10.1002/ana.20643 · Cited by 40
ALDP expression in fibroblasts of patients with X-linked adrenoleukodystrophy
Kemp, S., Mooyer, P. A. W., Bolhuis, P. A., van Geel, B. M., Mandel, J. L., Barth, P. G., Aubourg, P., & Wanders, R. J. A. (1996) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01799844 · Cited by 37
Self-citationThe AMC Linear Disability Score in patients with newly diagnosed Parkinson disease
Weisscher, N., Post, B., de Haan, R. J., Glas, C. A. W., Speelman, J. D., & Vermeulen, M. (2007) · Neurology · doi:10.1212/01.wnl.0000295666.30948.9d · Cited by 36
Addison's Disease in Association with Spastic Paraplegia
Penman, R. (1960) · BMJ · doi:10.1136/bmj.1.5170.402 · Cited by 34
Phenotype assignment in symptomatic female carriers of X-linked adrenoleukodystrophy
Schmidt, S., Träber, F., Block, W., Keller, E., Pohl, C., von Oertzen, T. J., Schild, H. H., Schlegel, U. S., & Klockgether, T. (2001) · Journal of Neurology · doi:10.1007/s004150170267 · Cited by 34
Salsano, E., Tabano, S., Sirchia, S. M., Colapietro, P., Castellotti, B., Gellera, C., Rimoldi, M., Pensato, V., Mariotti, C., Pareyson, D., et al. (2012) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-7-10 · Cited by 32
Kombination von Morbus Addison und Morbus Schilder bei einer 43 j�hrigen Frau
Pilz, P. K. D., & Schiener, P. (1973) · Acta Neuropathologica · doi:10.1007/bf00688083 · Cited by 31
Phenotypes of female adrenoleukodystrophy
Jung, H. H., Wimplinger, I., Jung, S. E., Landau, K., Gal, A., & Heppner, F. L. (2007) · Neurology · doi:10.1212/01.wnl.0000257129.51273.73 · Cited by 30
Is skewed X inactivation responsible for symptoms in female carriers for adrenoleucodystrophy?
Watkiss, E., Webb, T., & Bundey, S. (1993) · Journal of Medical Genetics · doi:10.1136/jmg.30.8.651 · Cited by 30
Aramideh, M., Hoogendijk, J. E., Aalfs, C. M., Meyjes, F. E. P., de Visser, M., & de Visser, B. W. O. (1992) · Journal of Neurology · doi:10.1007/bf00810353 · Cited by 18
Decreasing serum VLCFA levels in ageing X‐ALD female carriers
Stradomska, T. J., & Tylki‐Szymańska, A. (2001) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1013992224811 · Cited by 10
Aalfs, C. M., Koelman, J. H. T. M., Aramideh, M., Bour, L. J., Bruyn, R. P. M., & de Visser, B. W. O. (1993) · Journal of Neurology · doi:10.1007/bf00839966 · Cited by 10
[Carrier state of x-linked adrenoleukodystrophy].
van Geel, B. M. (2000) · PubMed · Cited by 3
Increased activity of surviving locus ceruleus neurons in Alzheimer's disease
Moser (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199901)45:1
Flagged first, then by citations
Research works printed but not linked: 1
- van Geel, 2000, Draagsterschap van X-gebonden adrenoleukodystrofie, Ned Tijdschr Geneeskd, 144, 1764
Cited by
Sorted by citations
Human disorders of peroxisome metabolism and biogenesis
Waterham, H. R., Ferdinandusse, S., & Wanders, R. J. A. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.11.015 · Cited by 384
Self-citationAdrenoleukodystrophy—Neuroendocrine pathogenesis and redefinition of natural history
Kemp, S., Huffnagel, I. C., Linthorst, G. E., Wanders, R. J., & Engelen, M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.90 · Cited by 275
Self-citationTurk, B. R., Theda, C., Fatemi, A. S., & Moser, A. B. (2020) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10003 · Cited by 212
Peroxisomes in brain development and function
Berger, J., Dorninger, F., Forss-Petter, S., & Kunze, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.12.005 · Cited by 194
X-Linked Adrenoleukodystrophy: Pathogenesis and Treatment
Engelen, M., Kemp, S., & Poll-The, B.-T. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0486-0 · Cited by 187
Self-citation
Metadata
- Authors
- Engelen, M., Barbier, M., Dijkstra, I. M. E., Schür, R., de Bie, R. M. A., Verhamme, C., Dijkgraaf, M. G. W., Aubourg, P. A., Wanders, R. J. A., van Geel, B. M., de Visser, M., Poll–The, B. T., & Kemp, S.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Assistance Publique – Hôpitaux de Paris (FR)
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-01-29
- Volume
- 137
- Issue
- 3
- Pages
- 693-706
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2150643970
- Cited by
- 234
- References
- 48
- Citations by year
- 2026: 15 · 2025: 17 · 2024: 23 · 2023: 10 · 2022: 28 · 2021: 35 · 2020: 19 · 2019: 18 · 2018: 18 · 2017: 9 · 2016: 14 · 2015: 16 · 2014: 11
- FWCI
- 11.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- female carriers, ABCD1 gene, peroxisomal disorders, very long chain fatty acids, adrenomyeloneuropathy, myelopathy, peripheral neuropathy, fecal incontinence, X chromosome inactivation, peroxisomal beta-oxidation, differential diagnosis
- MeSH terms
- ATP Binding Cassette Transporter, Subfamily D, Member 1, Adrenoleukodystrophy, Adult, Age Factors, Aged, Cross-Sectional Studies, Evoked Potentials, Female, Heterozygote, Humans, Middle Aged, Peripheral Nervous System Diseases, Prospective Studies, Spinal Cord Diseases, Cohort Studies, ATP-Binding Cassette Transporters, X Chromosome Inactivation, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
